| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Fust Matthew K is a Director at NMRA with holdings across 5 companies. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $1.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 12, 2021 | CRNX Crinetics Pharmaceuticals, Inc. | Director | Sale+OE | 5,000 | $20.71 | $103,550.00 | -28.5% | -5.6% | -1.9% | |
| Jul 6, 2020 | RARE Ultragenyx Pharmaceutical Inc. | Director | Sale+OE | 6,181 | $90.00 | $556,290.00 | -31.3% | - | - | |
| Jul 1, 2020 | RARE Ultragenyx Pharmaceutical Inc. | Director | Sale+OE | 5,000 | $85.00 | $425,000.00 | -27.0% | - | - | |
| May 18, 2020 | RARE Ultragenyx Pharmaceutical Inc. | Director | Sell | 1,875 | $75.00 | $140,625.00 | -14.6% | - | - | |
| Apr 22, 2020 | RARE Ultragenyx Pharmaceutical Inc. | Director | Sell | 1,875 | $65.00 | $121,875.00 | -12.7% | - | - | |
| Dec 16, 2019 | CRNX Crinetics Pharmaceuticals, Inc. | Director | Sale+OE | 3,500 | $22.50 | $78,750.00 | -21.8% | - | - | |
| Feb 6, 2019 | MGNX MacRogenics Inc | Director | Sale+OE | 6,924 | $29.38 | $203,427.12 | -93.3% | - | - | |
| May 30, 2018 | RARE Ultragenyx Pharmaceutical Inc. | Director | Sell | 6,319 | $72.00 | $454,969.26 | -41.9% | - | - | |
| May 14, 2018 | ATRA Atara Biotherapeutics, Inc. | Director | Sale+OE | 12,286 | $43.57 | $535,301.02 | -38.3% | - | - |